Information Provided By:
Fly News Breaks for August 5, 2016
REGN
Aug 5, 2016 | 07:59 EDT
After Regeneron reported lower than expected revenue, RBC Capital analyst Adrian Butt notes that Eylea revenue beat expectations, although the company expects Eylea selling costs to rise going forward. However, the analyst says that the company has numerous late stage studies that could provide multiple significant positive catalysts for the stock between 2016-2019 and onward. The analyst keeps an Outperform rating on the shares.